Have you ever walked into a doctor’s office feeling uncertain? You know you’re unwell, but you’re relying entirely on the physician to tell you *how* unwell, and exactly what tests or treatments you need. Now, add another layer: does how you *pay*-with cash from your wallet or with an insurance card-change the care you receive? This is one of the most complex and debated questions in health economics. We’re not just talking about medicine; we’re talking about a unique market where the seller (the doctor) also tells the buyer (the patient) what to buy. This creates a fascinating economic dance, especially when the doctor is dealing with two very different types of “customers”: the insured and the uninsured.
Table of Contents
The doctor’s information superpower
In most markets, you, the consumer, have a pretty good idea of what you want. If you’re buying a car, you know your budget and whether you need an SUV or a hatchback. But in healthcare, you’re at a significant disadvantage. You don’t have the medical training to diagnose yourself or confidently choose between ‘Treatment A’ and ‘Treatment B’. This gap in knowledge is what economists call information asymmetry.
Because the physician has all the information, they are in a powerful position. This power can lead to a phenomenon known as Supplier-Induced Demand (SID). In simple terms, SID is a situation where the supplier (the physician) uses their informational advantage to encourage a patient to consume more healthcare services than the patient would have chosen if they were fully informed. This doesn’t mean doctors are all trying to scam you. It could be a doctor recommending a slightly more expensive ‘precautionary’ MRI “just to be safe,” when a simpler X-ray might have been sufficient. The patient, lacking the expertise to argue, almost always agrees. This information gap is the fundamental reason the healthcare market doesn’t operate like a regular market for, say, bananas or smartphones.
One doctor, two markets
In a country like India, this dynamic is further complicated by a “dual market” system. The Indian healthcare sector is a mix of public hospitals, private out-of-pocket payments, and a growing insurance sector. A single private clinic or physician often operates in two distinct markets at the same time: the uninsured market and the insured market.
For the doctor, these two markets present completely different economic challenges and opportunities. Their strategy for one is not the same as for the other. They must wear two different hats: one as a “price setter” and one as a “price taker.”
The price setter: Facing the uninsured patient
When a patient walks in paying “out-of-pocket” (cash), the physician acts like a classic monopolist or a small business owner. They are a price setter. They face a traditional, downward-sloping demand curve.
What does this mean? It’s like a local gourmet coffee shop. The shop can set its price for a cappuccino. If they set it at ₹500, very few people will buy it. If they set it at ₹150, many more will. They have to find the “sweet spot” that maximizes their revenue. Similarly, the physician sets their own consultation fee. If they charge ₹2000, they might get fewer patients, but each one is very profitable. If they charge ₹500, their waiting room might be full, but they earn less per patient. The doctor has control over this price, and they know that charging more will mean seeing fewer uninsured patients.
The price taker: Facing the insured patient
When a patient presents an insurance card, the game changes completely. This is true for private insurance or government-sponsored schemes like Ayushman Bharat (PM-JAY). In this scenario, the doctor is not a price setter. They are a price taker.
The insurance company (or the government) has already decided what it will pay for that consultation or procedure. This is a pre-determined, non-negotiable fee, often called a reimbursement rate. The doctor is given a simple choice: accept this fixed fee as payment in full, or don’t treat the patient under that insurance. For the doctor, this creates a horizontal demand curve. It’s a flat line at the insurer’s set price (say, ₹400 per consultation). The doctor can’t charge ₹450, and they have no incentive to charge ₹350. They can see one patient or one hundred patients-the price for each is fixed at ₹400.
Finding the optimal patient mix
Now, let’s put ourselves in the physician’s shoes. They have a limited number of hours in the day (their “capacity” or “supply”) and they want to maximize their income. They have two groups of patients they can see. How do they decide?
They will follow a logical, profit-maximizing order. Let’s think about marginal revenue, which is the *additional* income the doctor gets from seeing just one more patient.
- For the insured patient: The marginal revenue is simple. It’s the fixed ₹400 fee. The first insured patient brings in ₹400, and the tenth insured patient also brings in ₹400.
- For the uninsured patient: This is more complex. Because they are on a downward-sloping demand curve, the marginal revenue is *not* the same as the price. To see one more cash patient, the doctor might have to slightly lower their price for *all* cash patients. Therefore, the marginal revenue from the uninsured market is always *less than* the price they charge.
So, here is the doctor’s optimal strategy:
- Start with the uninsured market. The first few uninsured patients are highly profitable. The doctor will continue to see uninsured patients as long as the marginal revenue from the *next* uninsured patient is greater than the guaranteed ₹400 they can get from an insured patient.
- Switch to the insured market. The doctor will reach a point where the marginal revenue from seeing *one more* uninsured patient (by, say, lowering their price to attract them) drops to ₹400. At this exact point, the doctor becomes indifferent. Why bother with the complexity of the uninsured market when the insured market offers a guaranteed ₹400?
- Fill remaining capacity. From this point on, the doctor will fill the rest of their available time and capacity by treating patients from the insured market, as each one provides a stable ₹400.
- Stop when the cost is too high. The doctor will stop seeing patients altogether when their marginal cost (the cost in time, energy, and supplies of seeing one more patient) rises to meet the marginal revenue (₹400).
This is a perfect example of third-degree price discrimination. The doctor segregates the market into two groups and charges them different prices (or, more accurately, accepts different revenues) for the exact same service, maximizing their total income in the process.
What happens when insurance prices fall?
This economic model has huge implications for public policy. Imagine the government or a large insurance company decides to cut costs. They announce they are lowering the reimbursement rate for a consultation from ₹400 to ₹300. What happens next?
The physician’s horizontal demand curve for the insured market drops to a new, lower level (₹300). Now, their calculations change:
- The doctor looks at their uninsured market again. Previously, they stopped seeing cash patients when their marginal revenue hit ₹400.
- Now, they will continue to see more uninsured patients, moving further down that demand curve, until their marginal revenue drops all the way to the new, lower rate of ₹300.
- This means the doctor is reallocating their time. They are taking time *away* from the less profitable insured market and giving it *to* the (now relatively more profitable) uninsured market.
This is a critical, and often counterintuitive, outcome. When the price in the insured market falls, the physician’s total output (number of patients seen) for that market decreases. Insured patients lose access. They may face longer wait times, or find that doctors are no longer “accepting new insured patients.” Conversely, uninsured patients may find their access *improves* as doctors are now more willing to compete for their business.
This explains a real-world tension. We often hear of private hospitals complaining that government scheme reimbursement rates are too low. They argue that the rates don’t cover their costs. As this model shows, when rates are set too low, suppliers (doctors and hospitals) will rationally shift their supply to more profitable markets (like out-of-pocket patients or those with better private insurance), leading to access problems for those covered by the lower-paying schemes.
A complex balancing act
Understanding the physician as both a price setter and a price taker isn’t about judging their motives. It’s about recognizing that they operate within a unique and complex economic system. They must balance their professional oath with the economic realities of running a practice. By facing a dual market, they perform a constant, complex calculation to allocate their most precious resource-their time-between patients who pay with cash and those who pay with insurance. This model helps us understand why healthcare access and pricing remain two of the most challenging puzzles for economists and policymakers to solve.
What do you think? If you knew insurance companies paid your doctor a lower fee, would you feel that your higher “out-of-pocket” payment was unfair? Or do you see it as a necessary part of a complex market?
Leave a Reply